ORMP Company Profile and Key Details
Oramed Pharmaceuticals Inc.
ORMP Stock Price Chart
Stock Price Today
Oramed Pharmaceuticals Inc. (ORMP) stock declined over -0.43%, trading at $2.30 on NASDAQ, down from the previous close of $2.31. The stock opened at $2.31, fluctuating between $2.25 and $2.31 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.
Company Information
| Employees | 13 |
| Beta | 1.77 |
| Sales or Revenue | $2.70M |
| 5Y Sales Change% | -0.785% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) stock price is $2.30 in the last trading session. During the trading session, ORMP stock reached the peak price of $2.31 while $2.25 was the lowest point it dropped to. The percentage change in ORMP stock occurred in the recent session was -0.43% while the dollar amount for the price change in ORMP stock was -$0.01.
The NASDAQ listed ORMP is part of Biotechnology industry that operates in the broader Healthcare sector. Oramed Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Miriam Kidron Ph.D.
Chief Scientific Officer & Director
Mr. Netanel Derovan
Chief Legal Officer & Company Sec.
Mr. Michael Rabinowitz
Chief Commercial Officer
Dr. Roy Eldor M.D., Ph.D.
Chief Medical Advisor & Member of the Scientific Advisory Board
Mr. David Silberman CPA
Chief Financial Officer & Treasurer
Mr. David Silberman C.P.A.
Chief Financial Officer & Treasurer
Mr. Nadav Kidron Esq.
Pres, Chief Executive Officer & Executive Chairman
Mr. Joshua Hexter
Chief Operating & Bus. Officer
ORMP's closing price is 15% higher than its 52-week low of $2.00 where as its distance from 52-week high of $3.67 is -37.33%.
Number of ORMP employees currently stands at 13.
Official Website of ORMP is: https://www.oramed.com
ORMP could be contacted at phone 844 967 2633 and can also be accessed through its website. ORMP operates from 1185 Avenue of the Americas, New York, NY 10036, United States.
ORMP stock volume for the day was 57.37K shares. The average number of ORMP shares traded daily for last 3 months was 154.11K.
The market value of ORMP currently stands at $92.72M with its latest stock price at $2.30 and 40.31M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com